Novartis (NOVN) Stock Overview

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

NOVN Stock Information

Symbol

NOVN

Address

Lichtstrasse 35Basel, 4056Switzerland

Founded

Trading hours

Website

https://www.novartis.com

Country

🇨🇭 Switzerland

Phone Number

41 61 324 1111

Novartis (NOVN) Price Chart

Novartis Overview: Key Details and Summary

Stock data	2023	Change
Price	$96.46	N/A
Market Cap	$198.26B	N/A
Shares Outstanding	2.06B	-5.76%
Employees	101.70K	N/A
Shareholder Equity	46.75B	-21.33%

Valuation	2023	Change
P/S Ratio	4.25	N/A
P/B Ratio	4.24	N/A
P/FCF	16.94	N/A
POE	0.00	N/A

Dividends	2023	Change
Dividend Yield	3.66%	N/A
Dividend per share	3.5296	N/A
Dividend Payout Ratio	0.4884	N/A

Growth	2023	Change
ROIC	0.1749	N/A
CAPEX	-823.00M	N/A
Return on Equity	0.3177	N/A

Earnings	2023	Change
Revenue	$46.66B	N/A
Earnings	$14.85B	N/A
Free Cash Flow	$11.71B	N/A
Gross Margin	0.7327	N/A
Operating Margin	0.2094	N/A
Net income margin	0.3183	N/A
FCF Margin	0.2509	N/A

Financial Strength	2023	Change
Total Assets	$99.94B	N/A
Total Debt	$26.35B	N/A
Cash on Hand	$13.96B	N/A
Debt to Equity	$1.14	16.52%
Cash to Debt	0.5299	-20.55%
POE	0.0000	N/A
Current Ratio	$1.16	-10.33%

Other data	2023	Change
Buyback Yield	0.0440	N/A